TY - JOUR
T1 - Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging
AU - Donal, Erwan
AU - Delgado, Victoria
AU - Bucciarelli-Ducci, Chiara
AU - Galli, Elena
AU - Haugaa, Kristina H.
AU - Charron, Philippe
AU - Voigt, Jens-Uwe
AU - Cardim, Nuno
AU - Masci, P. G.
AU - Galderisi, Maurizio
AU - Gaemperli, Oliver
AU - Gimelli, Alessia
AU - Pinto, Yigal M.
AU - Lancellotti, Patrizio
AU - Habib, Gilbert
AU - Elliott, Perry
AU - Edvardsen, Thor
AU - Cosyns, Bernard
AU - Popescu, Bogdan A.
AU - 2016–18 EACVI Scientific Documents Committee
AU - Gerber, Bernhard
AU - Muraru, Denisa
AU - Flachskampf, Frank
AU - Plein, Sven
AU - Neglia, Danilo
AU - Cameli, Matteo
AU - Weytjens, Caroline
N1 - Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Dilated cardiomyopathy (DCM) is defined by the presence of left ventricular or biventricular dilatation and systolic dysfunction in the absence of abnormal loading conditions or coronary artery disease sufficient to explain these changes. This is a heterogeneous disease frequently having a genetic background. Imaging is important for the diagnosis, the prognostic assessment and for guiding therapy. A multimodality imaging approach provides a comprehensive evaluation of all the issues related to this disease. The present document aims to provide recommendations for the use of multimodality imaging according to the clinical question. Selection of one or another imaging technique should be based on the clinical condition and context. Techniques are presented with the aim to underscore what is 'clinically relevant' and what are the tools that 'can be used'. There remain some gaps in evidence on the impact of multimodality imaging on the management and the treatment of DCM patients where ongoing research is important.
AB - Dilated cardiomyopathy (DCM) is defined by the presence of left ventricular or biventricular dilatation and systolic dysfunction in the absence of abnormal loading conditions or coronary artery disease sufficient to explain these changes. This is a heterogeneous disease frequently having a genetic background. Imaging is important for the diagnosis, the prognostic assessment and for guiding therapy. A multimodality imaging approach provides a comprehensive evaluation of all the issues related to this disease. The present document aims to provide recommendations for the use of multimodality imaging according to the clinical question. Selection of one or another imaging technique should be based on the clinical condition and context. Techniques are presented with the aim to underscore what is 'clinically relevant' and what are the tools that 'can be used'. There remain some gaps in evidence on the impact of multimodality imaging on the management and the treatment of DCM patients where ongoing research is important.
UR - http://www.scopus.com/inward/record.url?scp=85072508354&partnerID=8YFLogxK
U2 - https://doi.org/10.1093/ehjci/jez178
DO - https://doi.org/10.1093/ehjci/jez178
M3 - Article
C2 - 31504368
SN - 2047-2404
VL - 20
SP - 1075
EP - 1093
JO - European heart journal cardiovascular Imaging
JF - European heart journal cardiovascular Imaging
IS - 10
ER -